Global infection prevention and control priorities 2018-22: a call for action. by Allegranzi, Benedetta et al.
Allegranzi, B; Kilpatrick, C; Storr, J; Kelley, E; Park, BJ; Donaldson,
L; Global Infection Prevention and Control Network, (2017) Global
infection prevention and control priorities 2018-22: a call for action.
Lancet Glob Health, 5 (12). e1178-e1180. ISSN 2214-109X DOI:
https://doi.org/10.1016/S2214-109X(17)30427-8
Downloaded from: http://researchonline.lshtm.ac.uk/4645665/
DOI: 10.1016/S2214-109X(17)30427-8
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: https://creativecommons.org/licenses/by/3.0/igo/
Comment
www.thelancet.com/lancetgh   Vol 5  December 2017 e1178
Global infection prevention and control priorities 2018–22: 
a call for action
The Ebola virus disease outbreak in west Africa and 
the rapid spread of other emerging viruses, such as 
the severe acute respiratory syndrome or the Middle 
East respiratory syndrome coronaviruses, showed 
how limited or non-existent infection prevention 
and control (IPC) programmes, combined with an 
inadequate water supply, poor sanitation, and a weak 
hygiene infrastructure in health facilities, can threaten 
global health security. In such outbreaks, instead 
of serving as points where disease was controlled, 
health-care facilities became dangerous places for 
outbreak amplification among staff and patients 
and transmission back to communities. According to 
WHO, defective IPC practices during everyday health-
care delivery also cause harm to hundreds of millions 
of patients worldwide every year.1,2 The European 
Centre for Disease Prevention and Control estimated 
that more than 2·6 million new cases of health-care-
associated infection occur every year in Europe, with a 
cumulative burden estimated in disability-adjusted-
life-years that is higher than all other reported 
32 communicable diseases.3 The burden of health-care-
associated infections was also recently highlighted in 
southeast Asian countries.4 Many health systems fail to 
build strong foundations to reduce the risks and spread 
of health-care-associated outbreaks. They also tolerate 
an unacceptably poor level of IPC in everyday practice.
It is now urgent to consider IPC capacity building 
and actual implementation as global health priorities. 
This would create a unique opportunity to make 
IPC a strong contributor to the achievement of the 
health-related UN’s Sustainable Development Goals 
(particularly, 3.1-3, 3.b, 3.d, and 6), including quality 
universal health coverage (3.8).5 It would also help 
effective implementation of other major global 
health priorities, including the International Health 
Regulations, antimicrobial resistance (AMR) action 
plans, patient and health worker safety, and integrated 
people-centred care.6,7
Among its efforts in this field, WHO coordinates 
the Global IPC (GIPC) Network. This brings together 
major IPC organisations with the aim to enhance 
local, national, and international collaboration. It also 
supports country efforts in strengthening IPC systems 
and programmes, outbreak preparedness and response, 
and capacity building for surveillance. In early 2017, GIPC 
Network participants and WHO identified priorities for 
the next 5 years at both the country and global (panel) 
level. Together with the recent WHO guidelines on core 
components of IPC programmes,8 the new priorities will 
be a source of direction and focus for decision-makers 
and influencers at national and international health-
care levels.
Panel: Call for action
Priorities for IPC at country level
Countries where IPC has just started
• Decisive and visible political commitment, including IPC policy development and 
enforcement 
• Availability of resources (both human and infrastructure)
• Establishment and execution of IPC programmes at the national and acute health facility 
levels to ensure advocacy, training and data for future improvement and sustainability 
• Action to increase availability of in-country IPC knowledge and expertise
Countries with advanced IPC programmes
• Increased accountability with IPC as a quality indicator
• Development of advanced information technology tools to support IPC monitoring 
and implementation 
• Translation of information through enhanced communications to sustain awareness 
and engagement 
• Credible incentives considering the local context to increase compliance rates
• Enhanced education and training to embed IPC knowledge across all disciplines
Priorities for IPC at the global level
Strengthen IPC in the health system perspective
• Strengthen IPC visibility and advocacy: convince decision-makers and stakeholders
•  Lead on IPC knowledge development: create standardised curricula templates that can 
be adapted locally (“adapt to adopt”) and stimulate further research on priority areas
• Foster and promote IPC as a marker of quality: establish international IPC minimum 
standards 
• Build active networks and stronger communications:- ensure that patient safety and 
quality improvement leaders, as well as other health workers across all disciplines, are 
engaged to advocate for IPC
Elevate the role of IPC specifically to better combat AMR
• Strengthen the power to act: secure support for a “top-down” chief executive 
approach, empower IPC leads
• Improve evidence presentation to leaders: effectively outline available data and other 
information on the impact of IPC solutions on AMR
• Expand the narrative: help people visualise how IPC programmes can lead to AMR risk 
reduction
IPC=infection prevention and control. AMR=antimicrobial resistance.
Comment
e1179 www.thelancet.com/lancetgh   Vol 5  December 2017
Ebola virus disease and other outbreaks, as well as the 
seriousness of the seemingly inexorable march of AMR,9 
have been wake-up calls to political and public health 
leaders around the world. However, the relationship 
between these big picture global threats and the need 
to secure real and sustained IPC improvements in 
every country (panel) is not always fully appreciated. 
Inevitably, the pace at which change can be achieved in 
countries will vary for historical, logistical, and financial 
reasons. This should not detract from the realisation 
that political engagement, constant provision of the 
necessary resources for such a vital function, and the 
need for greater awareness and training, should be a 
priority everywhere.
At the global level (panel), there is a need for 
international organisations to recognise that global 
health security relies on effective IPC to control 
emerging health threats (including AMR) and that 
there is a need to intensify IPC support to countries and 
the international community. An early opportunity to 
convince global and national leaders of the value of IPC 
action is this year’s World Antibiotic Awareness Week 
which emphasises IPC among its core messages. While 
efforts such as new drug development are certainly 
needed, IPC is a tried-and-true approach that is likely 
to be cost-effective and with the capacity to sustain or 
even potentiate successes gained through new drug 
development or improving antibiotic use.
A number of common challenges and barriers 
still exist to accomplish these priorities, such as 
competing political agendas, resource constraints, and 
multiple promotional health messages. Additionally, 
despite strong evidence for the effectiveness of IPC, 
further research is needed to identify and validate 
innovative technologies and equipment to support 
IPC, provide a stronger demonstration of the cost-
effectiveness of IPC interventions, and identify feasible 
implementation approaches and local solutions for 
low-resource settings.
There are strong economic and ethical reasons to 
enhance IPC within the national and global health 
security agendas given both the burden and priorities 
outlined by the GIPC Network. Very recently, Tedros 
Adhanom Gehebreyesus, the new Director-General 
of WHO, has said, “Universal health coverage and 
health emergencies are cousins….Strong health 
systems are our best defense to prevent outbreaks 
from becoming epidemics”.10 Efforts should capitalise 
upon evidence-based recommendations, proven and 
feasible implementation strategies, and awareness 
raised by AMR and epidemic-prone disease threats. The 
GIPC Network Call for Action promotes coordination, 
synergy, accountability, and communication as essential 
means to make this happen.
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